Cookies?
Library Header Image
LSE Research Online LSE Library Services

Seroxat and the suppression of clinical trial data: regulatory failure and the convenience of legal ambiguity

McGoey, L. and Jackson, Emily (2009) Seroxat and the suppression of clinical trial data: regulatory failure and the convenience of legal ambiguity. Journal of Medical Ethics, 35 (2). pp. 107-112. ISSN 0306-6800

Full text not available from this repository.

Abstract

This article critically evaluates the Medicines and Healthcare products Regulatory Agency’s announcement, in March 2008, that GlaxoSmithKline would not face prosecution for deliberately withholding trial data, which revealed not only that Seroxat was ineffective at treating childhood depression but also that it increased the risk of suicidal behaviour in this patient group. The decision not to prosecute followed a four and a half year investigation and was taken on the grounds that the law at the relevant time was insufficiently clear. This article assesses the existence of significant gaps in the duty of candour which had been assumed to exist between drugs companies and the regulator, and reflects upon what this episode tells us about the robustness, or otherwise, of the UK’s regulation of medicines.

Item Type: Article
Official URL: http://jme.bmj.com/
Additional Information: © 2009 BMJ Publishing Group
Library of Congress subject classification: R Medicine > R Medicine (General)
Sets: Departments > Law
Research centres and groups > BIOS (Centre for the Study of Bioscience, Biomedicine, Biotechnology and Society)
Rights: http://www.lse.ac.uk/library/usingTheLibrary/academicSupport/OA/depositYourResearch.aspx
Date Deposited: 20 Jan 2009 12:45
URL: http://eprints.lse.ac.uk/21992/

Actions (login required)

Record administration - authorised staff only Record administration - authorised staff only